What Should You Demand from AI Echocardiography?
Not all AI echo is clinical-grade. Before you shortlist a vendor, these seven criteria separate a tool that genuinely detects disease from one that simply automates clicks. Use them to frame your evaluation, your RFP, and your clinical due diligence.
Evaluate the Capability, Not the Brochure
AI echocardiography is now a crowded market, and the marketing language has converged faster than the underlying capability. The criteria below are vendor-neutral: any serious buyer can apply them to any product. Where a criterion is easy to claim and hard to prove, we link to how Us2.ai approaches it so you can hold the answer to evidence.
A Checklist for Clinical-Grade AI Echo
- 01
Is it truly automated?
Manual frame selection and semi-automated steps quietly push work back onto the operator and reintroduce the variability automation is meant to remove. The standard to hold any AI to is full automation, from DICOM in to structured report out, with the reader reviewing rather than driving every measurement.
What good looks like: a hands-free pipeline the clinician approves, not a tool that asks for a click at every step.
See how Us2.ai automates the full workflow - 02
Does it detect disease, not just measure?
Measurements are necessary but not sufficient. A buyer should expect the AI to combine quantification with guideline criteria and pattern recognition, rather than leaving the entire diagnostic synthesis to the clinician.
What good looks like: disease-level output, for example aortic stenosis severity or amyloidosis likelihood, not just a table of numbers.
See the disease detection Us2.ai is cleared for - 03
Is the output guideline-compliant and explainable?
Reports should map to recognized recommendations from bodies such as the ESC, ASE, and BSE, and every value should trace back to the image and beat it came from. Explainability is what makes the output trustworthy for clinical sign-off, audit, and regulatory accountability under frameworks such as FDA clearance and EU MDR.
What good looks like: editable, traceable measurements a clinician can verify, not an opaque score.
Review Us2.ai regulatory status and clearances - 04
How strong is the clinical evidence?
Training-data volume is not the same as validation. The evidence that matters is peer-reviewed, published in credible journals, and generated across multiple sites and independent cohorts rather than a single internal dataset.
What good looks like: independent, multi-site publications you can read, not a marketing claim.
Browse the peer-reviewed evidence base - 05
Does it explain why, not just what?
A black-box disease label is clinically incomplete. HFpEF, for example, can arise from hypertension, amyloidosis, or hypertrophic cardiomyopathy, and each points to a different care pathway. Useful AI surfaces the underlying structural and functional findings alongside the result, so clinicians can act rather than simply confirm.
What good looks like: the markers behind the conclusion, such as wall thickness, strain pattern, and apical sparing, not just a yes or no flag.
See how Us2.ai surfaces the why behind heart failure - 06
Does it meet regulatory requirements in your market?
FDA clearance, CE marking under EU MDR, and MHRA approval are not interchangeable, and a clearance in one geography does not guarantee another. Confirm the solution is cleared for your specific intended use in your specific market.
What good looks like: a clear, current statement of clearances by country and intended use.
Check clearances by market - 07
Is it validated across your patient population?
Single-center or single-ethnicity datasets do not always travel. Multi-national, multi-vendor validation is what gives confidence that performance will hold on the patients and ultrasound systems in front of you.
What good looks like: validation spanning several countries, scanners, and demographics close to your own.
See the multi-cohort, multi-vendor validation
A framework is only useful if the answers hold up.
Put Us2.ai Against Every Criterion
Bring this checklist to a demo. We will walk through automation, disease detection, guideline mapping, evidence, explainability, clearances, and validation with the data behind each.